Open AccessInterleukin 6 and disease transformation in chronic myeloid leukemia: A Northeast Indian population study
Author(s) -
Keshav Sharma,
Usha Singh,
Madhukar Rai,
Jyoti Shukla,
Vineeta Gupta,
Gopeshwar Narayan,
Sandip Kumar
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_137_17
Subject(s) - myeloid leukemia , medicine , interleukin 6 , immunology , cytokine , leukemia , gastroenterology
Interleukin 6 (IL6) has been suggested to be a valuable prognostic marker in chronic myeloid leukemia (CML). IL6 is a pleiotropic cytokine and plays an important role in immune response, hematopoiesis, and acute phase response. IL6 is regarded as a prominent target for clinical interventions.